Table 5.
Clinical manifestations and complications from COVID-19 (N = 35).
| Author | No. | Unilateral Pneumonia No. (%) |
Bilateral Pneumonia No. (%) |
Ground Glass opacity No. (%) |
Acute Respiratory distress No. (%) |
RNA Anemia No. (%) |
Shock No. (%) |
Hospitalization No. (%) |
Discharge No. (%) |
Death No. (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| Chung et al.24 | 21 | 2 (1.5) | 16 (11.8) | 18 (13.2) | a | 21 (15.4) | a | 21 (15.4) | a | a |
| Chen et al.11 | 29 | a | a | 29 (100) | a | 29 (100) | a | 27 (9.1) | a | 2 (6.9) |
| Wang et al.25 | 138 | 0 (0) | 138 (100) | 138 (100) | 27 (19.6) | 138 (100) | 12 (8.7) | 138 (100) | 47 (34.1) | 6 (4.3) |
| Kui et al.26 | 137 | a | 36 (26.3) | 55 (40.1) | a | 137 (100) | a | 77 (56.6) | 44 (32.4) | 16 (11.8) |
| Chang et al.27 | 13 | 1 (7.7) | a | 6 (46.2) | a | 13 (100) | a | 12 (92.3) | 1 (7.7) | a |
| To et al.28 | 12 | a | a | a | a | 12 (100) | a | 12 (100) | a | a |
| COVID-19 team29 | 15 | a | a | a | a | 15 (100) | a | 11 (73.3) | a | a |
| Yueying et al.30 | 63 | a | 38 (60.3) | 14 (22.2) | a | 63 (100) | a | a | a | a |
| Li et al.31 | 24 | a | a | a | a | 24 (100) | a | a | a | a |
| Feng et al.32 | 21 | 18 (85.7) | a | a | a | 21 (100) | a | 21 (100) | a | a |
| Liang et al.33 | 1590 | a | a | a | a | a | a | 1590 (100) | a | a |
| Zhang et al.34 | 9 | 2 (2.22) | 5 (55.6) | 7 (77.8) | a | 9 (100) | a | 9 (100) | a | a |
| Feng et al.35 | 15 | 4 (26.7) | 8 (53.3) | a | a | 15 (100) | a | a | 15 (100) | a |
| Wang et al.17 | 34 | a | 34 (100) | 34 (100) | a | 34 (100) | a | 34 (100) | 34 (100) | a |
| Xiaobo et al.36 | 52 | a | a | a | 35 (67.3) | a | a | 52 (100) | a | 32 (61.5) |
| Xia et al.40 | 20 | 6 (30) | 10 (50) | 12 (60) | a | a | a | 20 (100) | a | a |
| Zhou et al.37 | 191 | a | 143 (75) | 136 (71) | 59 (31) | a | 38 (20) | 191 (100) | 137 (71.7) | 54 (28.3) |
| Wang et al.39 | 1 | 1 (100) | a | 1 (100) | a | a | a | 1 (100) | a | a |
| Qiu et al.38 | 36 | a | a | 19 (53) | a | a | 0 (0) | 36 (100) | a | a |
| Wan et al.41 | 135 | a | 135 (100.0) | a | 21 (15.6) | a | 1 (0.7) | 120 (88.9) | 15 (42.9) | 1 (0.7) |
| Liu et al.42 | 56 | 16 (28.6) | 40 (71.4) | a | a | a | 3 (5.4) | a | 53 (94.6) | 3 (5.4) |
| Zhao et al.43 | 19 | 15 (44.1) | 19 (55.9) | 18 (52.9) | a | a | a | a | a | a |
| Zhou et al.10 | 62 | 10 (16.1) | 52 (83.9) | 25 (40.3) | a | a | a | a | a | a |
| Wang et al.44 | 69 | a | a | a | a | a | a | 44 (65.7) | 18 (26.9) | 5 (7.5) |
| Lei et al.45 | 20 | 2 (10.0) | 18 (90.0) | 16 (80.0) | 1 (5.0) | a | 1 (5.0) | 6 (30.0) | 14 (70.0) | 0 (0.0) |
| Lei Pan et al.46 | 204 | a | a | a | a | a | a | a | 168 (82.35) | 36 (17.65) |
| Fan et al.47 | 150 | 67 (44.67) | 83 (55.33) | 93 (62.00) | a | a | a | a | a | a |
| Richardson et al.48 | 5700 | a | a | a | a | a | a | a | 82 (13.5) | 1381 (24.2) |
| Li et al.49 | 93 | 74 (80) | 17 (18) | a | a | a | a | a | 68 (73) | 25 (27) |
| Hong et al.50 | 98 | 14 (14.3) | 34 (34.7) | 42 (42.9) | 13 (13.3) | 9 (9.1) | 57 (58.2) | 30 (30.6) | 5 (5.1) | |
| Garazzino et al.51 | 168 | a | a | a | a | a | a | 110 (65.1) | a | a |
| Zacharia et al.52 | 50 | a | 25 (69) | a | a | a | a | a | a | 1 (2) |
| Matos et al.53 | 106 | 7 (6.6) | 99 (93.4) | 79 (74.5) | a | a | a | 97 (91.5) | 9 (8.5) | 25 (23.6) |
| Li et al.54 | 102 | a | a | a | a | a | a | 2 (1.96) | 85 (83.3) | 15 (14.7) |
| Alsofyan et al.55 | 1519 | a | a | a | a | a | a | 1087 (71.6) | a | 10 (0.65) |
No, number.
a
Data not available.